Analysis revealed that HCC patients with higher MARCH5 expression exhibited a trend toward poor prognoses, including reduced overall survival and recurrence‐free survival (Fig. 4a, b). The gene discussed is MARCHF5; the disease is hepatocellular carcinoma.